The accelerated cell death 11 (acd11) mutant of Arabidopsis provides a genetic model for studying immune response activation and localized cellular suicide that halt pathogen spread during infection in plants. Here, we elucidate ACD11 structure and function and show that acd11 disruption dramatically alters the in vivo balance of sphingolipid mediators that regulate eukaryotic-programmed cell death. In acd11 mutants, normally low ceramide-1phosphate (C1P) levels become elevated, but the relatively abundant cell death inducer phytoceramide rises acutely. ACD11 exhibits selective intermembrane transfer of C1P and phyto-C1P. Crystal structures establish C1P binding via a surface-localized, phosphate headgroup recognition center connected to an interior hydrophobic pocket that adaptively ensheaths lipid chains via a cleft-like gating mechanism. Point mutation mapping confirms functional involvement of binding site residues. A p helix (p bulge) near the lipid binding cleft distinguishes apo-ACD11 from other GLTP folds. The global two-layer, a-helically dominated, ''sandwich'' topology displaying C1P-selective binding identifies ACD11 as the plant prototype of a GLTP fold subfamily.
INTRODUCTION
Sphingolipids and their metabolites (i.e., ceramide [Cer] , ceramide-1-phosphate [C1P], and the long-chain bases [LCBs] sphingosine and sphingosine-1-phosphate [S1P]), are bioactive lipids that function as messenger signals and mediators of eukaryotic processes such as cell growth, development, embryogenesis, senescence, inflammation, and programmed cell death (PCD) (Fyrst and Saba, 2010; Hannun and Obeid, 2008; Michaelson and Napier, 2010) . The dynamic balance between Cer (sphingoid base amide linked to a fatty acyl chain) and its phosphorylated derivative, C1P, critically regulates PCD in plants and animals (Berkey et al., 2012; Chen et al., 2009; Pata et al., 2010; Reape and McCabe, 2008) .
In plants, PCD occurs during development, during disease symptoms associated with virulent infections, and during the hypersensitive response (HR) induced by avirulent stress effectors (Lam, 2004) . Hallmarks of HR are local accumulation of reactive oxygen species, nitric oxide, and the phytohormone, salicylic acid (SA). By inducing localized cell death triggered when resistance proteins recognize specific pathogen-derived molecules, HR potentiates defensive resistance. Mutants exhibiting accelerated cell death (acd) phenotypes in the absence of pathogen effectors also provide insights into HR-like PCD and defense activation. One HR mimic is the acd5 mutant, which lacks Cer kinase (CerK) activity and accumulates Cers, triggering PCD (Liang et al., 2003) . C1P addition partially abrogates the PCD-inducing effects of elevated Cer in acd5. In acd11 null mutant, HR-related PCD and defense genes are constitutively activated in a SA-dependent fashion. The acd11 gene encodes ACD11, a lipid transfer protein able to moderately accelerate the intermembrane transfer of sphingosine and sphingomyelin (SM), but not Cer or glycosylceramides (Brodersen et al., 2002; Petersen et al., 2008) .
Structural homology modeling predicts that ACD11 forms a GLTP fold and is a glycolipid transfer protein (GLTP) superfamily member (Airenne et al., 2006; Brown and Mattjus, 2007; Petersen et al., 2008) . Yet, ACD11 is unable to transfer glycolipids (Brodersen et al., 2002) , consistent with the lack of essential residues needed for glycosphingolipid (GSL) sugar headgroup binding (Petersen et al., 2008) . In mammalian GLTPs and HET-C2 fungal GLTP, X-ray structures reveal the molecular details of how glycolipids are recognized and bound by a conserved residue cluster (Asp, Asn, Lys, His, and Trp) that forms a hydrogen bond network with the GSL sugar-amide region, thus explaining the selectivity and transfer proficiency for various GSLs (Airenne et al., 2006; Kenoth et al., 2010 Kenoth et al., , 2011 Malinina et al., 2004 Malinina et al., , 2006 Samygina et al., 2011) . Currently lacking for ACD11 is the establishment of its preferred sphingolipid ligand as well as direct evidence for its functional involvement in the regulation of plant sphingolipid metabolism.
Herein, we investigated ACD11 structure and lipid transfer specificity and discovered high selectivity for C1P and phyto-C1P, but not related plant sphingolipids, i.e., glucosylceramides (GlcCers), Cer, glycosylinositolphosphoceramides (GIPCs), and sphingoid LCBs. X-ray structures establish ACD11 global architecture to be a GLTP fold and reveal the molecular basis for selective recognition of C1P. Point mutation functional analyses support structural mapping showing a cationic residue cluster mediating the selective binding of the C1P headgroup in a surface-located recognition cavity. An intrahelical distortion, i.e., p helix (p bulge), uniquely distinguishes ACD11 from other known GLTP folds including the recently discovered human ceramide-1-phosphate transfer protein (CPTP) . The p bulge involves key residues of the C1P recognition center that regulates access and encapsulation of the lipid hydrocarbon chains to an adjoining hydrophobic pocket. In Arabidopsis acd11 (acd11-1) null mutant, normally low C1P levels are elevated, whereas relatively abundant phytoceramides (phyto-Cers) rise acutely, consistent with shifts in the dynamic balance and distributions of these two sphingolipids playing a key role in plant PCD regulation.
RESULTS

ACD11 Forms a GLTP Fold with a Helical p Bulge in Its Lipid Headgroup Recognition Center
To experimentally establish if ACD11 forms a GLTP fold, we crystallized wild-type (WT) protein and determined its structure (1.8 Å ) (Tables S1 and S2). ACD11 adopts the two-layer, all a-helical ''sandwich'' motif characteristic of the GLTP fold ( Figure 1A) . Nonetheless, there are differences compared to the human GLTP fold prototype ( Figure S1 ). At the N terminus, ACD11 has an extra a helix (designated aN) that is lacking in human GLTP and is $35% shorter in human CPTP. Key residues involved in lipid headgroup recognition in ACD11 ( Figure 1B , cyan) differ in GLTP ( Figure 1B , pink), but not in CPTP ( Figure 1C , beige), except for conserved Asp60 and His143, residues needed for Cer interaction in all GLTP folds ( Figure S1A , red). The ACD11 C-terminal region does not directly contribute to formation of the headgroup recognition cavity as occurs in GLTP ( Figure 1B , red arrow) but resembles the HET-C2 fungal GLTP fold, which terminates similarly with a Trp residue (Kenoth et al., 2010) . In ACD11, C-terminal Trp206 positioning is stabilized by cation-pi interaction with Arg92, but no similar interaction occurs in GLTP or CPTP, which end with Val209 and Pro214, respectively. A relatively small, compact cavity for lipid headgroup binding exists in ACD11 and CPTP, a consequence of the a3/a4 loop projecting out and over in hood-like fashion ( Figure 1B , blue arrow; Figure 1C ). The nearby surface region is highly basic ( Figures 1D and 1F ) compared to its more neutral counterpart in human GLTP ( Figure 1E ). A noteworthy structural feature of apo-ACD11 is the p helix (p bulge) in helix a2 near Asp60 resulting in close proximity to His143 via a 2.9 Å salt bridge (Figures 1G and 1J) . In all other known apo-GLTP folds including CPTP, no p bulge occurs, and the analogous Asp and His residues remain further apart (Figures 1H and 1I) .
Crystal Structure of ACD11 in Complex with Lysosphingomyelin
The first tests of ACD11 transfer of GSL and related metabolites (Brodersen et al., 2002) preceded crystal structure determination of the human GLTP fold and mapping of the glycolipid binding site (Malinina et al., 2004) . GLTP and ACD11 superpositioning ( Figure 1B ) reveals a positively charged residue triad (K64, R99, and R103) in ACD11 replacing N52, L92, and W96 in GLTP. This explains the lack of glycolipid transfer by ACD11 and limited transfer of SM, which has a phosphocholine headgroup (Petersen et al., 2008) . Thus, initial trials focused on cocrystallization of WT-ACD11 complexed with SM and lysosphingomyelin (lysoSM) (Figure 2A ). Only the latter lipid yielded a crystal complex enabling 2.4 Å resolution (Figures 2B-2D; Table S1 ). The expected lipid-headgroup recognition cavity is occupied by a sulfate ion from crystallization solution. Also adsorbed nearby on the protein surface is the sphingoid chain of lysoSM. Notably, the choline headgroup moiety projects outward and away from the protein surface ( Figures 2B-2D ). One phosphate oxygen undergoes hydrogen bonding with the amide nitrogen of Gly144, whereas the sphingoid base amine hydrogen bonds with Asp60 ( Figure 2D ). The p bulge centered at Asp60 (a2 helix) persists in the ACD11/lysoSM complex. At the crystalpacking interface of the asymmetric unit, an additional lysoSM molecule is observed ( Figure S2A ).
ACD11 Is a C1PTP
Because plants contain no SM and do not produce this sphingolipid, SM transfer by ACD11 was surprising, suggesting that SM serves as a substitute analog for the plant lipid preferred in vivo (Petersen et al., 2008) . Also, as noted earlier, the lipid headgroup binding cavity is relatively small, compact, and hood-like (Figure 1B, blue arrow) , an arrangement expected to poorly accommodate the bulky SM phosphocholine headgroup. With that in mind, WT-ACD11 was analyzed for intermembrane transfer of other sphingolipids and phosphoglycerides. A Fö rster resonance energy transfer approach involving probe lipids with acyl-linked anthrylvinyl (AV) fluorophore enabled testing of lipids with phosphate headgroups, i.e., AV-phosphatidic acid (AV-PA) and AV-C1P, and controls, i.e., AV-galactosylceramide (AV-GalCer), AV-SM, and AV-Cer. ACD11 robustly transferred AV-C1P (sphingoid based), but not AV-PA (glycerol based) (Figures 2E and 2F) . Notably, ACD11 also transferred AV-phyto-C1P ( Fig in the ACD11 binding site. The sphingoid chains of ''phyto'' sphingolipid derivatives that predominate in plants lack the 4,5 trans double bond but contain a 4-hydroxy group (Markham et al., 2006 (Markham et al., , 2013 . The AV-C1P and AV-phyto-C1P transfer rates depended on protein concentration, required acceptor membranes ( Figures 3B, S3A , and S3B), and proceeded at $4.5 C1P and $5.6 phyto-C1P molecules/min/protein. Replacement of phosphate with sugar (AV-GalCer) prevented transfer by ACD11, but not by GLTP. AV-SM transfer by ACD11 was very slow ( Figure 2E ). The lack of AV-Cer transfer suggested a requirement for phosphate in the headgroup for functionality. This was confirmed by competition against AV-C1P transfer by lipids containing natural hydrocarbon chains ( Figure 2G ). Only nonfluorescent C1P competed strongly against AV-C1P ( Figure S3C ). IPC (inositolphosphoceramide), S1P, lysoSM, and N-hexyl(6:0)-SM (data not shown) exerted differing weak competition (Figures 2G and S3D-S3F). PA and lysoPA minimally slowed the initial AV-C1P transfer rate and were not effective competitors ( Figure S3G ).
Crystal Structure of D60N/D60A-ACD11 with Bound C1P
Due to the high transfer specificity for C1P, extensive cocrystallization trials were initiated for WT-ACD11 and C1P, but no positive outcome ensued. To achieve success, a point mutation strategy was used to weaken the Asp60-His143 salt bridge associated with the p bulge. We focused on Asp60 because mutation of the analogous Asp (D48V) in human GLTP is reasonably well tolerated (Samygina et al., 2011) . Asp60 was mutated to residues expected to weaken (Asn) or eliminate (Ala) salt bridging with H143. The D60N-ACD11 mutant maintained $25%-30% activity, whereas D60A-ACD11 was $10%-15% active compared to WT-ACD11 ( Figure 3B ).
Both the D60N and D60A mutants yielded crystal complexes with N-dodecanoyl-C1P (12:0-C1P) (Figure 3 ; Tables S1 and   S3 ), but not with other lipids (e.g., S1P, sphingosine, SM, lysoSM, or PA). In the D60N-ACD11/12:0-C1P crystal complex, the asymmetric unit consists of two ACD11 molecules containing 12:0-C1P bound in two ways ( Figures 3C-3F ). In one case, both the sphingosine and lauroyl acyl chain of 12:0-C1P are encapsulated in the hydrophobic pocket ( Figures 3C and 3E ). In the other case, only the lauroyl acyl chain is inserted into the hydrophobic pocket, whereas the sphingosine chain remains outside the pocket ( Figures 3D and 3F ). With D60A-ACD11/ 12:0-C1P complex, a different crystal form was observed involving one protein molecule with bound 12:0-C1P ( Figure 3G ; Tables S1 and S3 ). However, the overall structure resembled the sphingosine-out binding mode displayed by D60N-ACD11/12:0-C1P complex (Figures 3G and 3H) . Similar sphingosine-out conformers have been observed in human GLTP complexed with GSLs (Malinina et al., 2006; Samygina et al., 2011 Samygina et al., , 2013 and in human CPTP complexed with C1P . Similar positioning of different C1P species occurs in the hydrophobic pockets of ACD11 and CPTP except for the obvious differences in the bending angle of the outwardly projecting sphingoid chain in the sphingosine-out binding mode ( Figure S4) . The bending of sphingosine occurs immediately distal to the 4,5 trans double bond where carbon-carbon single bonds exist and torsional rotation is unrestrained, providing conformational optimization for packing at the crystal contact faces of ACD11 and CPTP.
Recognition of C1P by ACD11
It is noteworthy that the p bulge in apo-ACD11 (helix a2) disappears upon binding of C1P in both D60N-and D60A-ACD11, presumably reflecting C1P-induced conformational changes related to portal opening and entry of one or both C1P hydrocarbon chains into the hydrophobic pocket ( Figures 3G, 4A , and 4B). In both 12:0-C1P conformer complexes with D60N-and D60A-ACD11, the C1P group is anchored to positively charged residues on the protein surface via interaction of the three phosphate oxygen atoms with Lys64, Arg99, and Arg103 ( Figure 4C ). Their functional importance is illustrated by severe reductions in C1P transfer for the K64A, R99E, R99A, and R103A point mutants ( Figure 4F ). The C1P amide moiety hydrogen bonds with His143 and Asn60. The net effect is disruption of the stabilizing salt bridge and elimination of the p bulge characteristic of apo-ACD11. The hydrophobic pocket that accommodates the sphingosine and acyl chains of C1P is formed by a cluster of nonpolar residues, i.e., Leu, Val, Ile, Phe, Met, Ala, and Tyr, that line the two layers of the a helices in ACD11 ( Figure 4D ). Insertion and encapsulation of the 12:0-C1P hydrocarbon chains result in the disappearance of the intrahelical p bulge. This p helix-to-a helix structural transition involves large conformational changes for the side chains of several residues, i.e., Phe47, Phe54, Phe56, and Leu50 (Figure 4E) , which move toward the protein surface. This effectively expands the hydrophobic pocket and creates space to accommodate the hydrocarbon chains of 12:0-C1P. Introduction of polarity into the hydrophobic pocket by point mutation (F47Q-ACD11) leads to diminished activity ( Figure 4F ), affirming the importance of the hydrophobic environment. In the ''sphingosine-out'' structures, the nonpolar amino acids between helices a5 and a6 interact with the sphingoid chain via hydrophobic and van der Waals interactions enabling adsorption to the protein surface when encapsulation by the hydrophobic pocket does not occur.
Crystal Structure of D60A-ACD11 in Complex with N-Acetyl-C1P To define C1P features that contribute to the p helix-to-a helix transition needed for C1P chain insertion into the hydrophobic pocket, D60A-ACD11 was cocrystallized with bound N-acetyl(2:0)-C1P ( Figures 5A-5E ; Tables S1 and S3). As expected, the phosphate headgroup hydrogen bonds with Lys64, Arg99, and Arg103, but the bidentate hydrogen bonding of Arg99 observed with 12:0-C1P ( Figure 4C ) is reduced to a single hydrogen bond ( Figure 5C ). The acetyl chain amide group is unable to hydrogen bond with Ala60 and fails to hydrogen bond with His143 ( Figure 5C ), leaving the acetyl group on the surface, turned away from Ala60 and outside the hydrophobic pocket. The sphingosine chain also remains outside the hydrophobic pocket ( Figures 5B and 5E ), adsorbed between helices a5 and a6 on the protein surface. In this altered ''binding state,'' the p bulge persists, suggesting that transitioning of p helix to a helix is enhanced when the C1P acyl chain is long enough to enter the hydrophobic pocket ( Figure 5D ). From the functional standpoint, N-acetyl-C1P competes poorly against AV-C1P transfer by ACD11 ( Figure 5F ), as also is the case for S1P ( Figure 2G ). By contrast, N-acetyl-C1P competes moderately well against CPTP-mediated AV-C1P transfer , and the structure of the CPTP/N-acetyl-C1P complex shows no missing hydrogen bond interactions with the C1P-amide region, proper engagement of the N-acetyl group in the binding cleft, and encapsulation of the sphingoid chain in the hydrophobic pocket. The differences in position and conformation of bound N-acetyl-C1P molecules in ACD11 and CPTP are shown in Figure S5 .
Perturbations of Sphingolipid Levels in acd11-1 Mutants
To elucidate whether ACD11 involvement in Arabidopsis PCD manifests itself by altering sphingolipid metabolism, sphingolipid levels were profiled in dying leaves of homozygous acd11-1 mutants. An overall accumulation of total sphingolipids (Figure 6A) including LCBs ( Figure S6A ) is evident in acd11 compared to the Landsberg erecta (Ler) WT background, with total free Cers showing the greatest elevation. In plants, the dominant Cer species (>90%) are phyto-Cers (Markham et al., 2006 (Markham et al., , 2013 , which reportedly are more potent inducers of PCD than Cer (Hwang et al., 2001) . To verify and differentiate between effects caused by spontaneous cell death and reduced growth in acd11, we monitored sphingolipid levels upon PCD induction in acd11/NahG plants at 0, 12, 24, 72, and 120 hr after treatment with benzo(1,2,3)thia-diazole-7-carbothioic acid (BTH), a SA analog. Introduction of the bacterial transgene NahG into the acd11 background removes endogenous SA needed for development of the cell death phenotype. When acd11/NahG plants are then treated with BTH, cell death is fully reinstated. By 72 and 120 hr after BTH treatment ( Figure 6B ), a large increase in total Cer is evident compared to Ler and NahG controls, as well as a minor rise in 2-hydroxyceramide, which may reflect free Cer hydroxylation or increased sphingolipid turnover. In contrast, levels of GlcCer and GIPC remain largely unaltered ( Figure 6B ), suggesting that their increase in acd11 ( Figure 6A ) is probably due to reduced growth or the dwarf phenotype. Changes in levels of LCB(P), i.e., sphingoid-1-phosphates, also are insignificant in acd11 ( Figure S6B ) and, thus, may take more time or require stronger inductive conditions (e.g., higher BTH/SA levels) to develop. C1P, which occurs at extremely low levels at normal growth temperature, was not detected. The observed perturbations of sphingolipid levels reveal Cer accumulation during development of acd11 cell death, suggesting that ACD11 mediates Cer synthesis in a SAdependent manner.
Because cold temperature treatment of Arabidopsis induces substantial and rapid elevation of C1P and LCB(P) by a transduction process regulated by endogenous nitric oxide (Cantrel et al., 2011) , the responses of C1P and related sphingolipids to reduced temperature were analyzed in the acd11 background. Figure 7A shows that acd11 loss of function results in 3-to 5-fold elevations in the levels of different C1P species of plants subjected to cold treatment. These are quantitative determinations of C1P mass levels in plants, which were previously detected by radiolabeling (Cantrel et al., 2011) . Also evident are moderate increases in LCBP, but not LCB ( Figure 7B) , and Figure S5 and Tables S1 and S3. dramatic elevations of phyto-Cers (Figure 7C ). Interestingly, with phyto-Cer, the palmitoyl (16:0) species and very long acyl species (22-26 carbons) are most affected, whereas the elevations with C1P are shifted to the moderately long acyl species (16-22 carbons). These changes are consistent with a complex regulatory mechanism involving ACD11.
DISCUSSION
Unique Structural Aspects of the Lipid Headgroup Recognition Center and Hydrophobic Pocket of the ACD11 GLTP Fold
Despite low sequence homology of ACD11 and other GLTP homologs including human CPTP ( Figure S1A ), our crystallographic data establish the conserved structural homology shared by Arabidopsis ACD11, human GLTP, and human CPTP while revealing important differences. Unlike GLTP but like CPTP, ACD11 contains a modified lipid headgroup recognition center that selectively binds C1P, an important signaling lipid linked to cell survival. Comparison of ACD11, GLTP, and CPTP with their preferred bound lipids suggests adaptation and evolutionary conservation of key residues in their GLTP folds. The net outcome is two divergent subfamilies within the GLTP superfamily. Residues adapted to focus lipid specificity to C1P in ACD11 include Lys64 for Asn52, Arg99 for Leu92, and Arg103 for Trp96 in GLTP. The clustered Lys/Arg residues of ACD11 form a positively charged triad that is ideally arranged for binding phosphate, explaining the inability of ACD11 to bind sugar headgroups and transfer glycolipids (Petersen et al., 2008) . It is noteworthy that Arg103 occupies the same position where Trp acts as a stacking plate for the Cer-linked headgroup sugar in human GLTP, fungal HET-C2, plant GLTP1, and human FAPP2 West et al., 2008) . Conversely, residues analogous to Asp60 and His143 of ACD11 are absolutely conserved in the lipid headgroup recognition centers of all known GLTP folds. The ''pincher-like'' clamping that occurs when Asp and His hydrogen bond with the Cer moiety amide nitrogen and oxygen ensures a highly conserved and oriented entry of the sphingolipid hydrocarbon chains into the hydrophobic pocket regardless of lipid headgroup composition. The X-ray data rectify earlier 3D homology modeling involving identification of key residues of the ACD11 lipid headgroup recognition center and location of the C terminus, i.e., Trp206 (Airenne et al., 2006) .
A unique feature of the apo-ACD11 GLTP fold in comparison to other known GLTP folds including CPTP is the presence of p helix, i.e., p bulge, in helix a2 near the entrance portal of the lipid binding cleft (Figures 1G and 1J) . p bulges exist in only 15% of known proteins but often at locations that enhance/regulate function (Cartailler and Luecke, 2004; Cooley et al., 2010) . The p bulge in apo-ACD11 brings Asp60 and His143 sufficiently close (2.9 Å ) to form a salt bridge ( Figure 1G ), thus providing a potential regulatory mechanism for the ACD11 GLTP fold. In other GLTP folds, a water molecule often bridges the Asp and His residues ( Figure 1H ). In apo-ACD11, the Asp60-His143 salt bridge created by the p bulge appears to tightly seal the entry portal region of the hydrophobic pocket ( Figure 1G ). In D60A-ACD11, the p bulge persists after binding 2:0-C1P, but not 12:0-C1P, suggesting that salt bridge disruption between Asp60 and His143 by itself is insufficient to induce the p helixto-a helix conformational change needed for the ACD11/C1P complex to become ''transfer viable.'' In addition, the C1P acyl chain needs to be longer than only two carbons. This conclusion is supported by the structure of WT-ACD11 complexed with lysoSM, which has no acyl chain but displays a bound conformation resembling that of 2:0-C1P in D60A-ACD11 ( Figures 5 and  S2C) . LysoSM is tethered to the surface via its amine group interacting with Asp60, whereas a sulfate anion occupies the lipid headgroup (phosphate) binding pocket lending credence to the authenticity of the lysoSM binding site. Analogous behavior is observed in human GLTP/hexyl glucoside crystal complexes where the sugar headgroup occupies the glycolipid recognition center despite weak binding affinity and no measurable transfer (Malinina et al., 2006; Zhai et al., 2009 ). In the ACD11/lysoSM complex, occupation of the phosphate headgroup recognition center by the sulfate anion and the bulky, zwitterionic nature of the phosphocholine lipid headgroup are likely contributors to its minimal interaction and outward projection from the protein ( Figure S2A) . Similar conformation and surface localization are observed for the 2:0-C1P sphingosine chain in complex with D60A-ACD11 ( Figure S2 ). Thus, despite seemingly adequate positioning on the ACD11 surface, p bulge persistence renders the lipid binding interaction insufficient to drive robust transfer.
For ACD11 to become fully ''transfer viable,'' uptake of the sphingolipid acyl chain into the hydrophobic pocket and repositioning of specific residues appear to be required. At the molecular level, p bulge formation at Asp60 results in the Phe56 nonpolar phenyl ring projecting into the hydrophobic pocket to function as a ''portal gate'' that swings open during lipid acyl chain uptake ( Figure 4E ). Phe54 orients into the hydrophobic pocket providing conformational stability to apo-ACD11 in the absence of a lipid acyl chain. When C1P contains a sufficiently long acyl chain (e.g., 12:0-C1P), the acyl chain enters deep into the hydrophobic pocket, as shown for D60N-ACD11 and D60A-ACD11. A ''peristaltic-like shift'' of Ala57 to occupy the position of Phe56 as well as Phe54 being pushed outward accompanies transformation from p bulge to a helix, enabling hydrophobic pocket formation/expansion sufficient to accommodate either one or both hydrocarbon chains of Cer ( Figures  4D and 4E) . The key role played by Phe56 of helix a2 in functioning as a ''portal gate'' represents a fundamental difference between the ACD11 GLTP fold and human GLTP fold, which uses an ''oppositely located'' Phe (Phe148 of helix a6) as the ''portal gate'' that swings open during hydrocarbon chain insertion (Malinina et al., 2004; Samygina et al., 2011) . The global folding topology of ACD11 and conformational adaptability of its flexible, single-cavity, hydrophobic pocket contrast with Cer 
ACD11 Modulates Arabidopsis PCD by Intermediary Regulation of Sphingolipid Levels
The HR in plants generates localized cell death to minimize the spread of pathogens. HR-like PCD is also exhibited by the recessive acd11-1 mutant. Despite the known ties between ACD11 and HR-like PCD (Brodersen et al., 2002) , determination of the molecular structure and lipid specificity of ACD11 remained unclear until now. Establishment of ACD11 architecture as a C1P-selective GLTP fold capable of binding/transferring either C1P or phyto-C1P at similar rates provides insights into how this GLTP superfamily member impacts PCD-related processes regulated by key sphingolipid metabolites. Although fungal GLTP (HET-C2) and human FAPP2 (C-terminal GLTP-like domain) have both been implicated in PCD-related processes (Fedorova et al., 2005; Paoletti and Clavé , 2007; Tritz et al., 2009) , no sphingolipid analyses were performed upon in vivo depletion of these glycosylceramide-selective GLTP folds. Compared to mammals, plant membranes show fundamental differences in sphingolipid content including large contributions by GlcCer, GIPC, and modified sphingoid chains (e.g., phytoderivatives) as well as a lack of SM and gangliosides (Markham et al., 2006 (Markham et al., , 2013 Pata et al., 2010) . Adjustment to major lipid content during cold acclimation is well established in plants. Recent studies also show rapid elevations of low-level LCB(P)s and C1P (Cantrel et al., 2011) . The established signaling functions of such lipids make them leading candidates as early signals during cold acclimation. Because LCB(P) and C1P content is low under both normal and cold-stressed growth conditions, initial detection was accomplished by radiolabeling (Cantrel et al., 2011) . Determination of LCB(P) and C1P derivative mass levels has been challenging, a situation exacerbated by a dearth of authentic standards (Markham and Jaworski, 2007) . This has been especially true for C1P derivatives, which had not been mass quantified in plants until the present study. Our finding that acd11 deficiency not only alters C1P levels but also acutely elevates phyto-Cer levels (and LCBP to a lesser extent) establishes a functional link between acd11 expression and sphingolipid metabolic regulation in plants where the dynamic balance between Cer and C1P appears to be critical for regulating PCD (Chen et al., 2009; Liang et al., 2003; Pata et al., 2010; Reape and McCabe, 2008) . Although elevated C1P levels induced by acd11 disruption in Arabidopsis also are observed upon RNAi-induced depletion of the ACD11 ortholog CPTP in human cells, it is noteworthy that the dramatic elevations in phyto-Cer levels in acd11 mutants are not duplicated in the Cer levels of CPTP-depleted human cells . This suggests some differing aspects of ACD11 involvement in the regulation of sphingolipid metabolism in plants. Elucidating the mechanistic details and associated kinetics of this involvement will first require detailed analyses of plant sphingolipid metabolic pathways, related regulatory signaling pathways, and changes triggered during cold acclimation.
What is known is that the acd5 mutant lacks CerK activity, accumulates Cers, and exhibits PCD (Liang et al., 2003) . ACD11 may act in concert with ACD5 (CerK) to maintain the balance of Cer and C1P levels, thus controlling HR-associated PCD. In this context, the loss of IPC synthase activity (erh1 mutant) also results in total Cer accumulation, and both erh1 and acd5 exhibit enhanced HR-associated cell death triggered by the RPW8 resistance protein (Wang et al., 2008) . However, Cer accumulation and cell death in acd11, acd5, and erh1 are dependent on the phytohormone, SA. This suggests that perturbations in sphingolipid metabolism, such as occur in acd11, may regulate SA levels or signaling during R gene-mediated HR. Plant R proteins confer recognition of pathogen avirulence proteins and trigger effective innate immune responses (e.g., HR). A genetic screen for suppressors of acd11 cell death (laz mutants) identified the R gene LAZ5. Thus, the absence of ACD11 in acd11 leads to inappropriate HR activation by LAZ5 (Palma et al., 2010) . Because sphingolipids are important in both microbial pathogenesis and host defense (Heung et al., 2006) , LAZ5 may ''guard'' ACD11 function(s) in certain sphingolipid metabolic pathways targeted by pathogen effectors. Also, transgenic expression of human WT-GLTP and D48V-GLTP (Petersen et al., 2008) suppresses acd11 cell death, raising the possibility that the C1P binding/transfer activity of ACD11 is partially dispensable for PCD suppression. This could implicate LAZ5 as a response amplifier that triggers the HR when the local distribution and balance between phyto-Cer and C1P are disturbed, thereby intensifying the response through SA accumulation. Pathogen effector-induced modification or loss of function of ACD11 could interfere with normal sphingolipid distribution and trigger a defense response strong enough to deter microbial colonization. Because sphingolipid bases are upregulated early during an infection or HR, it is probable that sphingolipids are signaling mediators, and not the de facto cell death inducers via membrane perturbations (Mackey et al., 2003; Peer et al., 2010) . Testing this hypothesis will require research to clarify the interplay between cellular sphingolipid metabolism and basal immunity in plants.
It is also possible that loss of ACD11 as a selective carrier blocks C1P exit from the Golgi resulting in organelle stress, as occurs in human cells depleted of the ACD11 ortholog, CPTP , and leading to local accumulation of Cer that alters membrane component organization. Because ACD11 may be indirectly guarded (Palma et al., 2010) , triggering of HR cell death may not rely directly on the absence of ACD11 in the acd11 mutant. In mammals, nonmicrobial ''danger signals'' instigate obesity-induced inflammation via NLRP3, which senses increasing Cer and induces apoptosis (Vandanmagsar et al., 2011) , providing a potential clue as to how the HR might be induced in acd11 by LAZ5 via detection of the accumulation of specific sphingolipid species. Future localization studies on ACD11 and LAZ5 to evaluate possible corestriction in specific organelles could provide more insights.
EXPERIMENTAL PROCEDURES
Cloning, Expression, and Purification acd11-1 open reading frame (ORF; GenBank accession number NCBI NP_181016.1) expression in BL21(DE3) pLysS cells using pET-SUMO vector (Invitrogen) enabled Ni 2+ -NTA affinity chromatography purification of ACD11 N-terminally tagged with His 6 -SUMO (see Supplemental Experimental Procedures). Pure proteins were either used for crystallization immediately or flash frozen in liquid N 2 and stored at À80 C. ACD11 mutants were generated by PCR-based overlap extension and confirmed by DNA sequencing. Expression/purification was the same as for WT-ACD11.
Crystallization
A Mosquito crystallization robot (Molecular Dimensions) was used for initial cocrystallization screening of WT-ACD11 and the D60N and D60A mutants with lysoSM and C1P species (see the Supplemental Experimental Proce-dures). Positive hits were optimized using the hanging drop vapor diffusion method by varying pH and concentration of individual components (Table  S3 ). For data collection, crystals were flash frozen (100 K) in crystallization condition containing 25% (v/v) ethylene glycol. Diffraction data sets were collected on 24-ID-C and 24-ID-E beamlines at the Advanced Photon Source and X29A beamline at National Synchrotron Light Source. Collected data sets were integrated and scaled using the HKL2000 suite (Otwinowski and Minor, 1997) . All crystals have different packing interactions leading to different unit cell dimensions and space groups (Table S1 ).
Structure Determination and Refinement
Ab initio phasing was obtained by soaking apo-ACD11 crystals in 1 mM ethyl mercuric phosphate for 24 hr and collecting data (2.45 Å resolution) using a Rigaku RU-H3R X-ray generator equipped with a RAXIS-HTC detector (Table  S2 ). ACD11 structure was determined by the SIRAS method using Hg isomorphous as well as anomalous scattering data, with the 8 Hg sites located and refined for phasing using SHARP (Vonrhein et al., 2007) . apo-ACD11 crystals belonged to space group P2 1 2 1 2 1 and contained four protein molecules per asymmetric unit. The structures of ACD11-sphingolipid complexes were solved by molecular replacement (MOLREP program) using apo-ACD11 (Hg derivative) structure as the search model (Vagin and Teplyakov, 1997 ) (see the Supplemental Experimental Procedures).
ACD11 Intermembrane Lipid Transfer Activity
Fö rster resonance energy transfer provided kinetic insights into lipid transfer by ACD11. Donor POPC vesicles, containing 1 mol% AV-lipid acylated with (11E)-12-(9-anthryl)-11-dodecenoate and 1.5 mol% 1-acyl-2-[9-(3-perylenoyl)-nonanoyl]-3-sn-glycero-3-phosphocholine (Per-PC) were prepared by rapid ethanol injection (Mattjus et al., 1999) . In competition assays, donor vesicles contained 1 mol% AV-C1P (Boldyrev et al., 2013) as well as 0.5, 1.0, or 2.0 mol% competitor lipids (Samygina et al., 2011) . Both fluorescent lipids were present initially only in donor vesicles where minimal AV emission occurs upon excitation (370 nm) because of energy transfer to Per-PC. ACD11 addition results in an exponential increase in AV emission intensity as the protein transports AV-C1P from donor vesicles (creating separation from the ''nontransferable'' Per-PC) and delivers to the 10-fold excess POPC acceptor vesicles. The time-dependent increase in AV emission at 425 nm, relative to baseline fluorescence in the absence of ACD11, yields the AV-C1P transfer kinetics (see the Supplemental Experimental Procedures).
Plant Material and Sphingolipid Analyses acd11-1, acd11/NahG, and NahG plants in Ler background have been described by Brodersen et al. (2005) . For sphingolipid analyses, plants were grown in soil under short days (8 hr light/16 hr dark) in chambers at 150 mE/m 2 s, 21 C, and 70% relative humidity. Ler WT and acd11-1 mutants were grown untreated for 4 weeks before sampling. acd11-1/NahG together with NahG and Ler plants were grown for 5 weeks prior to spraying with the SA analog BTH (100 mM) and sampling after 0, 12, 24, 72, and 120 hr. Leaf material was harvested from three biological replicates for each genotype and time point. Sphingolipid analysis was performed by mass spectrometry (Bielawski et al., 2009; Markham and Jaworski, 2007) . Free and total LCBs were analyzed by HPLC after fluorescent derivatization (Bach et al., 2008) .
ACCESSION NUMBERS
The atomic coordinates and structure factors for the crystal structures of Arabidopsis WT-ACD11 and mutants in complex with various lipids were deposited in the Protein Data Bank under accession numbers 4NT1 (apo-ACD11), 4NT2 (ACD11/lysoSM), 4NTI (D60N-ACD11/12:0-C1P), 4NTG (D60A-ACD11/12:0-C1P), and 4NTO (D60A-ACD11/2:0-C1P).
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